Nakano-Kobayashi A.
,
Fukumoto A.
,
Morizane A.
,
Nguyen D. T.
,
Le T. M.
,
Hashida K.
,
Hosoya T.
,
Takahashi R.
,
Takahashi J.
,
Hori O.
,
Hagiwara M.
… Here, we identified novel therapeutic candidate ALGERNON2 (altered generation of neurons 2) and demonstrate that ALGERNON2 suppressed the production of proinflammatory cytokines and rescued neurodegeneration in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)–induced Parkinson's disease model. …
IR